Article 01 Sep 2023 Federal Circuit Invalidates Patent Term Adjustments For Obviousness-Type Double Patenting United States IP
Article 22 Apr 2022 Does PTAB's Ex Parte Cellect Decision Endanger Biopharmaceutical Patent Terms? United States IP
Article 19 Apr 2022 Does The PTAB's Recent Ex Parte Cellect Decision Signal Concern For The Valuable Patent Terms Of Biopharmaceuticals? United States IP